Steatosis and NASH in type 2 diabetes

被引：45

作者：

Hu, Mengyue ^{[1
,2
]}

Phan, Franck ^{[1
,2
]}

Bourron, Olivier ^{[1
,2
,3
,4
]}

Ferre, Pascal ^{[1
,2
]}

Foufelle, Fabienne ^{[1
,2
,3
,4
]}

机构：

[1] Sorbonne Univ, INSERM UMRS 1138, Ctr Rech Cordeliers, F-75006 Paris, France

[2] Univ Paris Diderot, Ctr Rech Cordeliers, Sorbonne Paris Cite, Univ Paris Descartes, F-75006 Paris, France

[3] AP HP, Dept Endocrinol Nutr & Diabet, Paris, France

[4] Hop La Pitie Salpetriere, AP HP, ICAN, Paris, France

来源：

BIOCHIMIE | 2017年 / 143卷

关键词：

Steatosis; NASH; Insulin resistance; Inflammation; Lipotoxicity; Type; 2; diabetes; FATTY LIVER-DISEASE; DE-NOVO LIPOGENESIS; NF-KAPPA-B; INSULIN-RESISTANCE; HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; IKK-BETA; RISK; OBESITY; MICE;

D O I：

10.1016/j.biochi.2017.10.019

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Non Alcoholic Fatty Liver Disease (NAFLD) is currently the most common chronic liver disease in the world, encompassing various conditions ranging from simple steatosis, steatohepatitis, to fibrosis and cirrhosis. The association between NAFLD and Type 2 Diabetes (T2D) is strong and complex, given that the prevalence of NAFLD is particularly high in individuals with Type 2 Diabetes. In fact, insulin resistance occurring in this metabolic disease can promote NAFLD development, and vice versa, NAFLD can enhance insulin resistance. In this review, we focus on the mechanisms linking NAFLD and T2D, including fatty acid accumulation, inflammation, oxidative stress etc. We also discuss about situations showing a dissociation between steatosis and insulin resistance, in order to provide new insights for NAFLD therapeutic targets. (C) 2017 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.

引用

页码：37 / 41

页数：5

共 50 条

[31] Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes
Alluri, K.
Srinivas, B.
Belmadani, S.
Matrougui, K.
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[32] T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes
Touch, Sothea
Clement, Karine
Andre, Sebastien
CURRENT DIABETES REPORTS, 2017, 17 (09)
[33] Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes
Petit, J. M.
Guiu, B.
Duvillard, L.
Jooste, V.
Brindisi, M. C.
Athias, A.
Bouillet, B.
Habchi, M.
Cottet, V.
Gambert, P.
Hillon, P.
Cercueil, J. P.
Verges, B.
CLINICAL NUTRITION, 2012, 31 (04) : 520 - 525
[34] OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetes
Melander, Simone Anna
Kayed, Ashref
Andreassen, Kim Vietz
Karsdal, Morten Asser
Henriksen, Kim
EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 962
[35] A Simple Test to Identify the Risk of NASH and Cirrhosis in People with Obesity or Diabetes: The Time to Screen Is Now
Cusi, Kenneth
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07) : E3076 - E3077
[36] Insulin resistance and type 2 diabetes in children
Castorani, Valeria
Polidori, Nella
Giannini, Cosimo
Blasetti, Annalisa
Chiarelli, Francesco
ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 25 (04) : 217 - 226
[37] The nonhuman primate as a model for type 2 diabetes
Pound, Lynley D.
Kievit, Paul
Grove, Kevin L.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (02) : 89 - 94
[38] Is FTO a type 2 diabetes susceptibility gene?
Meyre, D.
DIABETOLOGIA, 2012, 55 (04) : 873 - 876
[39] Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes
Zheng, Jing-Quan
Wang, Kun
Pei, Dee
Chen, Yen-Lin
Chang, Yen-Lin
Hsu, Chun-Hsien
Huang, Tsan-Ming
Lin, Mei-Yu
Lin, Pao-Ying
Lin, Jiunn-Diann
INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (03) : 372 - 376
[40] MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH
Zarfeshani, Aida
Ngo, Sherry
Sheppard, Allan M.
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (11): : 1938 - 1950

← 1 2 3 4 5 →